Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Hoffmann

Showing results (231-240 of 242) with videos related to

Pageof 25
Sort By:
Psychotherapie, Psychosomatik, Medizinische Psychologie|September 1, 1996
[Operationalized Psychodynamic Diagnosis in a trial--results of multicenter acceptability and practicability study]H J Freyberger, B Dierse, W Schneider, et al.
Paediatric Anaesthesia|August 19, 2010
Insufflation vs intubation during esophagogastroduodenoscopy in childrenClifford O Hoffmann, Paul J Samuels, Eileen Beckman, et al.
Pharmacogenetics and Genomics|February 14, 2009
Bioinformatic and functional analysis of TGFBR1 polymorphismsMarkus A Schirmer, Arne O Hoffmann, Radu Campean, et al.
Journal of Virology|September 6, 2005
In-depth analysis of a heterosexually acquired human immunodeficiency virus type 1 superinfection: evolution, temporal fluctuation, and intercompartment dynamics from the seronegative window period through 30 months postinfectionF E McCutchan, M Hoelscher, S Tovanabutra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 18, 2023
Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trialN Harbeck, P A Fasching, R Wuerstlein, et al.
ESMO Open|November 10, 2022
A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE)M Schmidt, K Lübbe, T Decker, et al.
ESMO Open|November 28, 2021
Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study programV Müller, M Banys-Paluchowski, T W P Friedl, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2010
A putatively functional haplotype in the gene encoding transforming growth factor beta-1 as a potential biomarker for radiosensitivityMarkus A Schirmer, Jürgen Brockmöller, Margret Rave-Fränk, et al.
Breast Cancer Research and Treatment|October 15, 2013
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patientsAnja Welt, Mitra Tewes, Bahriye Aktas, et al.
ESMO Open|August 15, 2025
Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292)M Hamann, M Christgen, O Gluz, et al.
Pageof 25

Showing results (231-240 of 242) with videos related to

Sort By:
Pageof 25
Psychotherapie, Psychosomatik, Medizinische Psychologie|September 1, 1996
[Operationalized Psychodynamic Diagnosis in a trial--results of multicenter acceptability and practicability study]H J Freyberger, B Dierse, W Schneider, et al.
Paediatric Anaesthesia|August 19, 2010
Insufflation vs intubation during esophagogastroduodenoscopy in childrenClifford O Hoffmann, Paul J Samuels, Eileen Beckman, et al.
Pharmacogenetics and Genomics|February 14, 2009
Bioinformatic and functional analysis of TGFBR1 polymorphismsMarkus A Schirmer, Arne O Hoffmann, Radu Campean, et al.
Journal of Virology|September 6, 2005
In-depth analysis of a heterosexually acquired human immunodeficiency virus type 1 superinfection: evolution, temporal fluctuation, and intercompartment dynamics from the seronegative window period through 30 months postinfectionF E McCutchan, M Hoelscher, S Tovanabutra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 18, 2023
Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trialN Harbeck, P A Fasching, R Wuerstlein, et al.
ESMO Open|November 10, 2022
A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE)M Schmidt, K Lübbe, T Decker, et al.
ESMO Open|November 28, 2021
Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study programV Müller, M Banys-Paluchowski, T W P Friedl, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2010
A putatively functional haplotype in the gene encoding transforming growth factor beta-1 as a potential biomarker for radiosensitivityMarkus A Schirmer, Jürgen Brockmöller, Margret Rave-Fränk, et al.
Breast Cancer Research and Treatment|October 15, 2013
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patientsAnja Welt, Mitra Tewes, Bahriye Aktas, et al.
ESMO Open|August 15, 2025
Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292)M Hamann, M Christgen, O Gluz, et al.
Pageof 25